Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $1.0 million.

  • Harvard Bioscience's Long-Term Debt Repayments changed 0.0% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 3071.19%. This contributed to the annual value of $6.0 million for FY2024, which is 4722.56% up from last year.
  • Per Harvard Bioscience's latest filing, its Long-Term Debt Repayments stood at $1.0 million for Q3 2025, which was down 0.0% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Long-Term Debt Repayments registered a high of $3.0 million during Q1 2024, and its lowest value of $500000.0 during Q1 2021.
  • For the 5-year period, Harvard Bioscience's Long-Term Debt Repayments averaged around $963157.9, with its median value being $750000.0 (2022).
  • Per our database at Business Quant, Harvard Bioscience's Long-Term Debt Repayments crashed by 9892.84% in 2021 and then surged by 9668.8% in 2023.
  • Quarter analysis of 5 years shows Harvard Bioscience's Long-Term Debt Repayments stood at $500000.0 in 2021, then surged by 50.0% to $750000.0 in 2022, then changed by 0.0% to $750000.0 in 2023, then soared by 33.33% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
  • Its Long-Term Debt Repayments was $1.0 million in Q3 2025, compared to $1.0 million in Q2 2025 and $1.0 million in Q1 2025.